Stay updated with breaking news from Arix Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A British biotechnology investment company previously backed by Neil Woodford is considering winding itself down after a slump in valuations in the sector.Arix Bioscience has launched a strategic review after discussions with shareholders. Arix said its board believed it could still deliver attracti
ARIX | Complete Arix Bioscience PLC stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
By Joe Hoppe Arix Bioscience said Thursday that it has begun a strategic review of its strategy and assets in order to assess how it can best deliver...
Arix Bioscience PLC on Thursday announced its net asset value had increased, but that it plans to launch a strategic review concerning issues like its discounted share price. The London-headquartered...
Arix Bioscience PLC - London-headquartered venture capital company focused on biotechnology companies - Says its portfolio company Disc Medicine has raised USD157.8 million via a placing of 3.0 million new shares and pre-funded warrants to purchase 204,0...